Oncotelic Therapeutics presents at Drug Discovery 2026
- Presented PDAOAI platform with 29 million PubMed abstracts
- Discussed four-gene mTOR-related signature for HCC
- Launched BIO REBOOT initiative for research projects
OTLC
Oncotelic Therapeutics, Inc. SEC filings
Every EDGAR filing for Oncotelic Therapeutics, Inc. (OTLC), newest first, with AI summaries and stories.
- Ticker
- OTLC
- CIK
- 908259
- Sector
- Biotech and pharma
- Latest filing
- 6d
Next: 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE NOTABLE10-QOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE Seymour Howard Fein, insider filing for OTLC
Seymour Howard Fein, reporting
ROUTINEDOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE Steven W King, insider filing for OTLC
Steven W King, reporting
ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE 4 insider filings
Vuong Trieu, insider filing for OTLC
Show all 4
- 4Insider filing for OTLC
- 4Insider filing for OTLC
- 4Insider filing for OTLC
- 4Insider filing for OTLC
Vuong Trieu, reporting
ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE Vuong Trieu, insider filing for OTLC
Vuong Trieu, reporting
ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE Vuong Trieu, insider filing for OTLC
Vuong Trieu, reporting
ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE Amit B. Shah, insider filing for OTLC
Amit B. Shah, reporting
ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE Vuong Trieu, insider filing for OTLC
Vuong Trieu, reporting
NOTABLE10-QOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE NOTABLE10-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE NOTABLENT 10-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE Vuong Trieu, insider filing for OTLC
Vuong Trieu, reporting
ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINEEFFECTOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE424B3Oncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE ROUTINES-1/AOncotelic Therapeutics, Inc.OTLCLIVE ROUTINEDOncotelic Therapeutics, Inc.OTLCLIVE ROUTINE8-KOncotelic Therapeutics, Inc.OTLCLIVE NOTABLES-1Oncotelic Therapeutics, Inc.OTLCLIVE Oncotelic Therapeutics, Inc. filed S-1
- Form Type: S-1
- Filing Date: 2025-11-21
ROUTINE4Oncotelic Therapeutics, Inc.OTLCLIVE Oncotelic Therapeutics, Inc. - Insider ownership filing (4)
- Insider ownership filing (4)
- Reports beneficial ownership changes
Vuong Trieu, reporting
NOTABLENT 10-QOncotelic Therapeutics, Inc.OTLCLIVE